AI-based drug screening platform for age-related therapies
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
5,060
NCT00212316
Safety and Tolerability Study of Phenylbutyrate in Huntington's Disease (PHEND-HD)
Phase: Phase 2
Role: Collaborator
Start: Aug 31, 2005
Completion: Jun 30, 2006
NCT00313495
Cooperative Huntington's Observational Research Trial
Phase: N/A
Role: Lead Sponsor
Start: Feb 28, 2006
Completion: Dec 31, 2020
Loading map...